MSC Workshop on Potency Assays

Pre-Conference Workshop
Wednesday, May 2
08:30 - 16:15

Organized by the ISCT MSC Scientific Committee

The MSC pre-conference workshop is themed on improving MSC potency and survival. It will examine ways to improve clinical efficacy using MSC potency assays and methods of improving MSC engraftment/homing/potency in vivo. Discussion of patient “Responders” vs. “Non-responders” in clinical trials, and working toward ways to identify them, will be included.

Supporters

Program Information

Chair:
Don Phinney, PhD, The Scripps Research Institute, United States


Speakers:
Predicting the Clinical Efficacy of MSC-Based Therapies
Don Phinney, PhD, The Scripps Research Institute, United States

High Throughput Approaches to Assess MSC Function
Steven R. Bauer, PhD, U.S. Food and Drug Administration (FDA), United States

Improving MSC-Based Gene and Cell Therapy
Massimo Dominici, MD, University of Modena and Reggio Emilia, Italy

Chair:
Jan Nolta, PhD, University of California Davis, United States

Speakers:

Pre-Conditioning of MSCs to Improve Engraftment and Function
Jan Nolta, PhD, University of California Davis, United States

MSC Potency in Septic Shock
David Courtman, PhD, Ottawa Hospital Research Institute, Canada

Scaffolds to Enhance the Regenerative Properties of Mesenchymal Stromal Cells
Armand Keating, MD, Princess Margaret Hospital, Canada

Chair:
Katarina LeBlanc, MD, PhD, Karolinska Institutet, Sweden

Speakers:

Mechanistic Insights into Patient Response Rates for MSC-Based Therapies
Katarina LeBlanc, MD, PhD, Karolinska Institutet, Sweden

Adipose-Derived Cells in Clinical Trials of Regenerative Medicine
Eleuterio Lombardo, PhD, TiGenix SAU, Spain

MSC-Based Therapies for Acute Respiratory Distress Syndrome
Michael Matthay, MD, University of California San Francisco, United States

MSC Nanotubules as a Cell-to-Cell Communication System in Acute Respiratory Distress
Anna Krasnodembskaya, PhD, Queen’s University of Belfast, United Kingdom

Chair:
Jacques Galipeau, MD, FRCP(C), University of Wisconsin-Madison, United States

 

Speakers:

MSCs in Clinical Use – Where to Now?
Jacques Galipeau, MD, FRCP(C), University of Wisconsin-Madison, United States

Trial Design: Cell Replacement or Cell Enpowerment?
Yufang Shi, PhD, Shanghai Institutes for Biological Sciences, China

To view full meeting program, please refer to the program schedule.

Confirmed Chairs and Speakers

Steven R. Bauer, PhD, U.S. Food and Drug Administration (FDA), United States
David Courtman, PhD, Ottawa Hospital Research Institute, Canada
Massimo Dominici, MD,
 University of Modena and Reggio Emilia, Italy
Jacques Galipeau, MD FRCP(C),
University of Wisconsin in Madison, United States
Armand Keating, MD, Princess Margaret Hospital, Canada
Katarina LeBlanc, MD, PhD, Karolinska Institutet, Sweden
Eleuterio Lombardo, PhD, TiGenix SAU, Spain
Michael Matthay, MD, University of California San Francisco, United States 
Jan Nolta, PhD, 
University of California Davis, United States
Donald G. Phinney, PhD, The Scripps Research Institute, United States
Yufang Shi, PhD, Shanghai Institutes for Biological Sciences, China

Organizing Committee

Jan A. Nolta, PhD, University of California Davis, United States  – Co-Chair

Donald G. Phinney, PhD, The Scripps Research Institute, United StatesCo-Chair